Falling share prices in the banking sector especially interfered with several high-profile merger plans, and shareholders in bank stocks and owners of securitisations all waited nervously to see if their assets would be hit by fallout from the US subprime loans problem. Nonetheless, there were many reasons for market participants to be cheerful as overall volumes of announced M&A and DCM activity increased, and some pioneering Japanese firms consolidated domestically or sought to expand overseas. Euromoney’s inaugural Japan deals of the year highlights the year’s outstanding deals, chosen because they were well-executed, because they were especially bold or unusual in concept, and because they exemplify expected trends in capital markets in the near future.
The Euromoney Japanese Digest has published a comprehensive list of deals of the year. The full list of winners is:
Best M&A deal (Japanese target): Permira’s acquisition of Arysta Lifescience
You do not currently have access to this content. To gain access visit the subscription page or call our hotline on +44 (0)207 779 8999.
Are you already registered? If so, please enter your username and password here to continue.
Know your email address?
Click here for your password.
Questions about your subscription status?
Email us or call: +44 (0) 20 7779 8888
Subscribers to Euromoney benefit from:
- Exclusive access to euromoney.com - Read the latest issue early online, search for specific developments by region or sector, interrogate the results of Euromoney's benchmark polls, and view the archive dating back to 2000.
- 12 monthly issues of Euromoney magazine
- More than 30 specialist research guides free
- The results of Euromoney’s polls and surveys
Click here to subscribe